|
|
Volumn 18, Issue 12, 2004, Pages
|
|
Less acid + less bleeding = better outcomes and more money!
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIULCER AGENT;
BENZIMIDAZOLE DERIVATIVE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP;
SULFOXIDE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DRUG ANTAGONISM;
ECONOMICS;
GASTROSCOPY;
HEALTH CARE COST;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
PEPTIC ULCER BLEEDING;
STOMACH ACID;
STOMACH ULCER;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ANTI-ULCER AGENTS;
BENZIMIDAZOLES;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
ENZYME INHIBITORS;
GASTRIC ACID;
GASTROSCOPY;
HEALTH CARE COSTS;
HUMANS;
INFUSIONS, INTRAVENOUS;
OMEPRAZOLE;
PEPTIC ULCER HEMORRHAGE;
PROTON PUMPS;
STOMACH ULCER;
SULFOXIDES;
TREATMENT OUTCOME;
|
|
EID: 16644383168
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2004/152140 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
